Search alternatives:
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
16281
-
16282
-
16283
-
16284
Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
16285
Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
16286
Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
16287
Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
16288
Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
16289
A binding mode landscape for disordered protein interactions.
Published 2020“…Context-dependent <b>disorder-to-order</b> binding is exemplified by the <b>polymorphic interactions</b> of the ribosomal S6 kinase 1 (RSK1, residues 697–703, <i>light blue dots</i>), which adopts different secondary structures upon binding to S100B, corresponding to autoinhibited and active forms (PDB:5csf, 5csi, 5csj [<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007864#pcbi.1007864.ref023" target="_blank">23</a>]). …”
-
16290
Effect of MMP9 on phFAK and ILK expression.
Published 2023“…<p>(A, B) Comparative phFAK expression in jck-MMP9+/+ and jck-MMP9-/- kidneys. …”
-
16291
-
16292
-
16293
A story about oxygen nanobubbles (RNS60)
Published 2014“…In addition, Revalesio states that RNS60 decrease muscle fatigue and improve exercise performance.[6]</p> <p>Reliant Water is a sport beverage produced by Revalesio and available to the public at the price of $100 USD per 32 bottles. …”
-
16294
-
16295
Examination of mitochondrial function and cell viability in <i>PLA2G6</i>-KD cells.
Published 2015“…(B) Expression levels of CCO are decreased in <i>PLA2G6</i>-KD cells compared with those of SH-SY5Y cells treated with negative control siRNA with statistical significance (*<i>p < 0</i>.…”
-
16296
-
16297
-
16298
-
16299
Effects of heterogeneity and noise on homeostatic stability of a network.
Published 2015“…The curve represents the mean maximal recurrence allowed to ensure a stable system. It decreases with heterogeneity. …”
-
16300
Behavior of a dynamic cytoskeleton under shear flow.
Published 2017“…<p>(a) <i>I</i><sub>2</sub>/<i>I</i><sub>1</sub> over time for <i>k</i><sub>off</sub> = 0, 10, and 100 s<sup>−1</sup>, (b) The lower effective shear modulus for a dynamic network leads to a higher dimensionless capillary number and greater deformations, as evidenced by the greater maximum value of <i>I</i><sub>1</sub> for the network with the fastest rate of remodeling, (c) The total number of irreversibly broken edges is plotted versus time. …”